Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions

Authors:

Abstract
No abstract available
Funding Information
  • Pfizer
  • Apellis Pharmaceuticals

This publication has 25 references indexed in Scilit: